We ran a flow cytometry experiment where Fc blockers were added into the antibody cocktail. Other antibodies added include:

1. anti-CD3-PE-Cy7

2. anti-CD4-APC

3. anti-CD8-AmCyan

4. anti-CD14-APC-Cy7

5. anti-CD19-BV605

6. anti-pSTAT1-AF488

7. anti-pTAT3-PE

8. anti-pSTAT5-BV421

Before Fc blockers were added, the monocyte population expressed high levels of CD3. We speculated that the anti-CD3 antibody might undergo non-specific binding to FcR. However, adding Fc blockers did not change the CD3 expression.

Is there any possible scenario of why this happened?

More Kezia Singgih's questions See All
Similar questions and discussions